Related Experiment Video
Updated: Apr 15, 2026

06:07
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.4K
Morphologic changes in the mesolimbic pathway in Parkinson's disease motor subtypes
Eric M Nyberg1, Jody Tanabe1, Justin M Honce1
1Department of Radiology, University of Colorado Denver, Aurora, CO, United States.
Parkinsonism & Related Disorders
|March 31, 2015
Summary
Parkinson's disease patients showed increased hippocampal volume compared to controls. Differences in nucleus accumbens shape were observed, particularly in the tremor-dominant subtype, suggesting potential impacts of treatment.
Area of Science:
- Neuroimaging
- Neurodegenerative Diseases
- Brain Anatomy
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder linked to gray matter atrophy.
- Cortical atrophy patterns may differentiate PD motor subtypes.
- Subcortical volume differences between subtypes are not well-established.
Purpose of the Study:
- To investigate subcortical volumetric and shape differences in Parkinson's disease patients.
- To compare these differences between tremor-dominant (TD) and postural instability gait dominant (PIGD) subtypes.
- To explore potential correlations with clinical measures.
Main Methods:
- Structural MRI scans (3.0T) were acquired from 21 PD patients (12 TD, 9 PIGD) and 20 controls.
- Subcortical volumes were analyzed using FreeSurfer.
- Shape analysis was performed using FIRST to detect differences between groups and subtypes.
Main Results:
- No significant subcortical volume differences were found between PD motor subtypes.
- PD patients exhibited significantly increased hippocampal volume compared to controls (p=0.03).
- Significant shape differences in the right nucleus accumbens (NAcc) were found between PD patients and controls, and between subtypes, driven by the TD group.
Conclusions:
- While subcortical volumes did not differ between PD subtypes, hippocampal volume was elevated in PD patients.
- Right NAcc shape alterations in PD were primarily associated with the TD subtype.
- These findings may reflect dopaminergic therapy effects on the mesolimbic pathway; further research is warranted.
Related Concept Videos
Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Neural Regulation
45.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K

